Pinz Capital Management’s Atara Biotherapeutics ATRA Stock Holding History

Pinz Capital Management’s Portfolio ATRA Stock Details ATRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-4,420	Closed	-$2.17M	–	300
2020 Q4	$2.17M	Buy	+4,420	New	+$2.04M	0.99%	46
2020 Q3	–	Sell	-6,444	Closed	-$2.35M	–	121
2020 Q2	$2.35M	Buy	+6,444	New	+$1.63M	1.08%	33

Other funds holding ATRA

Baupost Group Boston, Massachusetts $5.42B AUM 22.93% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Pinz Capital Management's ATRA Position: Q1 2021 in Review

Pinz Capital Management sold out of Atara Biotherapeutics (ATRA) in Q1 2021, closing a stake of 4,420 shares — an estimated $2.17M sold.

Pinz Capital Management first reported a position in ATRA in Q2 2020 and held it in 2 quarters. The position peaked at $2.35M in Q2 2020. 151 funds tracked by Wall St. Rank hold ATRA as of Q1 2021.

Pinz Capital Management reported no remaining Atara Biotherapeutics position as of Q1 2021 after selling out during the quarter.
Pinz Capital Management sold 4,420 Atara Biotherapeutics shares in Q1 2021, an estimated $2.17M.
Pinz Capital Management first reported a position in Atara Biotherapeutics in Q2 2020 and held it in 2 quarters.
Pinz Capital Management's Atara Biotherapeutics position peaked at $2.35M in Q2 2020.
151 funds tracked by Wall St. Rank held Atara Biotherapeutics as of Q1 2021.

Based on Pinz Capital Management's 13F filing for Q1 2021, filed 17 May 2021.